• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (3)
    • Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
    • Expression of the platelet-activating factor receptor in human spermatozoa: differences in messenger ribonucleic acid content and protein distribution between normal and abnormal spermatozoa.
    • Influence of Sacubitril/Valsartan (LCZ696)?on?30-Day Readmission After Heart Failure Hospitalization.
    • See All 3 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Effective treatment of hypereosinophilic syndrome with imatinib mesylate.

Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003; 4(6):410-2.

View in: PubMed

subject areas
  • Adult
  • Base Sequence
  • Benzamides
  • Child
  • Chromosomes, Human, Pair 8
  • DNA Primers
  • Enzyme Inhibitors
  • Fusion Proteins, bcr-abl
  • Humans
  • Hypereosinophilic Syndrome
  • Imatinib Mesylate
  • Karyotyping
  • Leukocyte Count
  • Male
  • Middle Aged
  • Piperazines
  • Protein-Tyrosine Kinases
  • Pyrimidines
  • Receptor, Platelet-Derived Growth Factor beta
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Trisomy

authors with profiles
  • Miguel Raul Abboud